Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapyOriginal Article Published on 2023-01-192024-09-05 Journal: Microbes and infection [Category] update2024, [키워드] Autoimmunity COVID-19 Ocrelizumab rituximab T-cells vaccination [DOI] 10.1016/j.micinf.2023.105103 PMC 바로가기 [Article Type] Original Article
Prolonged SARS -CoV-2 Infection With Common Features in Two Patients Receiving Anti-CD20 TherapyResearch Article Published on 2023-01-032024-09-05 Journal: In vivo (Athens, Greece) [Category] update2024, [키워드] cellular immunity chronic lymphocytic leukemia COVID-19 obinutuzumab rheumatoid arthritis rituximab SARS-CoV-2 [DOI] 10.21873/invivo.13100 PMC 바로가기 [Article Type] Research Article
Evolución clínica de 31 pacientes adultos con trombocitopenia inmune tratados con rituximabAportación Original Published on 2023-01-012024-09-04 Journal: Revista médica del Instituto Mexicano del Seguro Social [Category] 대상포진, [키워드] Immune thrombocytopenia rituximab Trombocitopenia Autoinmune PMC 바로가기 [Article Type] Aportación Original
COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritisArticle Published on 2022-12-232023-07-08 Journal: Rheumatology (Oxford, England) [Category] COVID19(2023년), [키워드] biologics COVID-19 Epidemiology RA rituximab SARS-CoV-2 vaccination [DOI] 10.1093/rheumatology/keac241 PMC 바로가기
Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal AntibodiesCase Reports Published on 2022-12-152023-07-10 Journal: Internal medicine (Tokyo, Japan) [Category] COVID19(2023년), [키워드] COVID-19 frequently relapsing/steroid-dependent nephrotic syndrome minimal change disease monoclonal antibody therapy REGEN-COV rituximab [DOI] 10.2169/internalmedicine.0241-22 PMC 바로가기 [Article Type] Case Reports
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyArticle Published on 2022-12-012023-07-10 Journal: Annals of the rheumatic diseases [Category] COVID19(2023년), [키워드] COVID-19 rituximab vaccination [DOI] 10.1136/ard-2022-222579
Seroconversion among rituximab-treated patients following SARS-CoV-2 vaccine supplemental doseArticle Published on 2022-12-012023-07-10 Journal: Clinical immunology (Orlando, Fla.) [Category] COVID19(2023년), [키워드] Autoimmune diseases B cells COVID-19 hypogammaglobinemia rituximab vaccination [DOI] 10.1016/j.clim.2022.109144 PMC 바로가기
Induction of cross-reactive, mucosal anti-SARS-CoV-2 antibody responses in rheumatoid arthritis patients after 3rd dose of COVID-19 vaccinationArticle Published on 2022-12-012023-07-10 Journal: Journal of autoimmunity [Category] COVID19(2023년), [키워드] RA rituximab salivary antibodies SARS-CoV-2 [DOI] 10.1016/j.jaut.2022.102918 PMC 바로가기
Nirmatrelvir/ritonavir as a potential treatment for prolonged SARS-CoV-2 infection in immunocompromised patientsArticle Published on 2022-12-012023-07-10 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), [키워드] Combination COVID-19 Nirmatrelvir Ritonavir rituximab SARS-CoV-2 [DOI] 10.37201/req/078.2022 PMC 바로가기
The optimal interval before receiving SARS-COV-2 vaccination for patients who have received Anti-CD 20 monoclonal antibodiesReview Published on 2022-12-012023-07-10 Journal: Virulence [Category] COVID19(2023년), [키워드] anti-CD20 COVID-19 rituximab SARS-CoV-2 Vaccine [DOI] 10.1080/21505594.2022.2146380 PMC 바로가기 [Article Type] Review